RGEN
Repligen Corporation
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$167.60
−1.19%0
Insider buys (3m)
3
Insider sells (3m)
-$1.2M
Net value (3m)
+37.7%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 2, 2026 | Hughes Violetta · officer: CHIEF ACCOUNTING OFFICER | A-Award | 2,466 | $0.00 |
| Sep 2, 2026 | Hughes Violetta · officer: CHIEF ACCOUNTING OFFICER | F-InKind | 277 | $170 |
| Aug 21, 2026 | Loeillot Olivier · director, officer: Chief Executive Officer | Sale | 5,426 | $180 |
| Aug 21, 2026 | Loeillot Olivier · director, officer: Chief Executive Officer | M-Exempt | 5,426 | $142 |
| Jul 17, 2026 | Garland Jason K · officer: CFO | Sale | 530 | $150 |
| Jun 26, 2026 | Garland Jason K · officer: CFO | Sale | 733 | $145 |
| May 18, 2026 | BARTHELEMY NICOLAS · director | A-Award | 2,239 | $103 |
| May 18, 2026 | Madaus Martin D · director | A-Award | 2,239 | $103 |
| May 18, 2026 | BARTHELEMY NICOLAS · director | A-Award | 995 | $0.00 |
| May 18, 2026 | Mhatre Rohin · director | A-Award | 2,239 | $103 |
| May 18, 2026 | Konstantinov Konstantin · director | A-Award | 2,239 | $103 |
| May 18, 2026 | Mhatre Rohin · director | A-Award | 995 | $0.00 |
| May 18, 2026 | Madaus Martin D · director | A-Award | 995 | $0.00 |
| May 18, 2026 | EGLINTON MANNER CARRIE · director | A-Award | 995 | $0.00 |
| May 18, 2026 | DAWES KAREN A · director | A-Award | 2,239 | $103 |
| May 18, 2026 | Konstantinov Konstantin · director | A-Award | 995 | $0.00 |
| May 18, 2026 | EGLINTON MANNER CARRIE · director | A-Award | 2,239 | $103 |
| May 18, 2026 | Pax Margaret · director | A-Award | 2,239 | $103 |
| May 18, 2026 | Pax Margaret · director | A-Award | 995 | $0.00 |
| May 18, 2026 | MUIR GLENN P · director | A-Award | 2,239 | $103 |
| May 18, 2026 | DAWES KAREN A · director | A-Award | 995 | $0.00 |
| May 18, 2026 | MUIR GLENN P · director | A-Award | 995 | $0.00 |
| May 8, 2026 | MUIR GLENN P · director | M-Exempt | 2,434 | $39 |
| May 8, 2026 | Douglass Brian Robb · officer: CHIEF PRODUCT OFFICER | F-InKind | 334 | $126 |
| Apr 22, 2026 | Loeillot Olivier · director, officer: Chief Executive Officer | Sale | 3,832 | $140 |
| Mar 23, 2026 | Loeillot Olivier · officer: Chief Executive Officer | A-Award | 25,890 | $142 |
| Mar 23, 2026 | Bylund James · officer: Chief Operating Officer | A-Award | 7,751 | $0.00 |
| Mar 23, 2026 | KURIYEL RALF · officer: Senior VP, R&D | A-Award | 5,669 | $142 |
| Mar 23, 2026 | KURIYEL RALF · officer: Senior VP, R&D | A-Award | 5,284 | $0.00 |
| Mar 23, 2026 | Loeillot Olivier · officer: Chief Executive Officer | A-Award | 24,134 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 166Increased 341Reduced 280Sold out 57
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BLACKROCK, INC. | Reduced | 5,993,054 | May 13, 2026 |
| BlackRock, Inc. | Reduced | 5,384,938 | Aug 7, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | Increased | 4,878,141 | May 15, 2026 |
| FMR LLC | Increased | 3,326,690 | Aug 13, 2026 |
| FMR LLC | Increased | 2,886,786 | May 15, 2026 |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC | Increased | 2,790,650 | Aug 17, 2026 |
| UNITED CAPITAL FINANCIAL ADVISERS, LLC | Increased | 2,773,980 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 2,411,171 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 2,396,511 | May 15, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Increased | 2,312,825 | Aug 13, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 2,305,094 | May 8, 2026 |
| MAVERICK CAPITAL LTD | Increased | 1,984,554 | Aug 14, 2026 |
| STATE STREET CORP | Increased | 1,800,530 | Aug 7, 2026 |
| STATE STREET CORP | Increased | 1,777,285 | May 15, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | Reduced | 1,752,274 | Aug 14, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 2, 2026